Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic Gαq Signaling Remodels the Tumor Surfaceome and Rewires Intracellular Networks in Uveal Melanoma Models. | Cancers (Basel) | 2026 | 42352426 | PubTator, text mining | PubMed |
| Analysis of Phosphorylated MEK1 Expression Pattern in Cutaneous Dilated Vessels of Capillary Malformations. | J Dermatol | 2026 | 42298299 | PubTator, text mining | PubMed |
| Choroidal melanoma edge recurrence 13 years after I125 plaque brachytherapy. | Am J Ophthalmol Case Rep | 2026 | 42292164 | PubTator, text mining | PubMed |
| Hypocalciuria as a Key to Diagnosis: A Rare Case of GNA11-Related Familial Hypocalciuric Hypercalcemia (FHH) Type 2. | Cureus | 2026 | 42291983 | PubTator, text mining | PubMed |
| Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology. | Clin Endocrinol (Oxf) | 2026 | 42272448 | PubTator, text mining | PubMed |
| Types of phacomatosis pigmentovascularis associated with nevus cesius. | Acta Dermatovenerol Alp Pannonica Adriat | 2026 | 42241635 | PubTator, text mining | PubMed |
| Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells. | J Invest Dermatol | 2026 | 42216948 | PubTator, text mining | PubMed |
| Canonical and noncanonical heterotrimeric G-protein signaling in uveal melanoma: Established mechanisms and emerging spindle-orientation hypotheses. | Biochem Pharmacol | 2026 | 42214764 | PubTator, text mining | PubMed |
| Radiologic-pathologic correlation in meningeal melanocytosis: A case report. | Medicine (Baltimore) | 2026 | 42152395 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Monitoring in Patients with Uveal Melanoma Using Mutation-Agnostic Multiplex Drop-Off ddPCR Assays. | Anal Chem | 2026 | 42082165 | PubTator, text mining | PubMed |
| Clinical and molecular characterization of familial hypocalciuric hypercalcemia in an endocrine practice: a case series of 25 patients. | JBMR Plus | 2026 | 42038813 | PubTator, text mining | PubMed |
| Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi. | J Cutan Pathol | 2026 | 42017541 | PubTator, text mining | PubMed |
| Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11 and GATA3 Mutations. | Clin Endocrinol (Oxf) | 2026 | 41952051 | PubTator, text mining | PubMed |
| A Novel KDR Mutation in an Infant With a Non-Involuting Congenital Hemangioma. | Pediatr Dermatol | 2026 | 41923709 | PubTator, text mining | PubMed |
| Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma. | Cancer | 2026 | 41906217 | PubTator, text mining | PubMed |
| Pigmented epithelioid melanocytoma: two cases with dermoscopic findings. | An Bras Dermatol | 2026 | 41875732 | PubTator, text mining | PubMed |
Melanomas arising in blue nevi exhibit absence of TERT promoter mutations, low tumor mutational burden, and high frequency of distant metastases and disease-related mortality: a clinicopathologic and molecular study of 11 cases. | Virchows Arch | 2026 | 41872493 | PubTator, text mining | PubMed |
| Retrospective study of photodynamic therapy for the GNA-Related Capillary Malformation spectrum of pediatric patients. | Photodiagnosis Photodyn Ther | 2026 | 41864397 | PubTator, text mining | PubMed |
| Increased Frequency and Distinct Genotypic Patterns of Somatic Aldosterone-Driver Mutations in Aldosterone-Producing Micronodules from Primary Aldosteronism Patients. | Endocr Pathol | 2026 | 41857472 | PubTator, text mining | PubMed |
A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report. | J Int Med Res | 2026 | 41852233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=2